The $3,000 mattress cover company that billionaires love wants to become a healthcare company
Eight Sleep, the startup behind the $2,999 mattress cover that puts both Elon Musk and Mark Zuckerberg to…
Enveda Moves Ahead To Address Post-GLP-1 Weight Loss Maintenance – insights.citeline.com
Enveda Moves Ahead To Address Post-GLP-1 Weight Loss Maintenance insights.citeline.comA pill that mimics exercise? Early results on drug designed…
From GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality matters
What does it really take to recreate one of today’s most talked-about medicines? As semaglutide gains traction worldwide,…
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
Adult B-ALL exhibits significant heterogeneity and poor prognosis compared with the pediatric population. While the complete remission (CR)…
An Oral Ketamine Drug for Depression — Minus the Trip?
A novel oral ketamine drug was well tolerated and associated with reduced depressive symptoms in treatment-resistant depression (TRD)…
TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia
TG Therapeutics, Inc. Phase 2 trial to evaluate the effects of B-cell depletion with BRIUMVI in approximately 60…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
Eledon Pharmaceuticals, Inc. Tegoprubart-treated patients maintained higher mean eGFR over time, including a statistically significant approximately 12 mL/min/1.73…
Fish oil supplements may not prevent Alzheimer’s-related decline
LOS ANGELES — Americans spend more than $1 billion annually on fish oil supplements, in part due to purported cognitive…
Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it
On Thursday morning in New York City, Dr. Shiv Rao stood before a room of health system executives…
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
TG Therapeutics, Inc. 82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement…
The Supplement That Science Says Could Make the World Less Angry
If you found out a supplement existed that could lower aggression, you would probably think it was something…